TRON performs collaborative research on disease genomics  and therapeutic modulation of the immune system.  Specializing in cancer immunology and genomics, our research teams develop tailored bioinformatic and novel biostatistical approaches to identify and characterize disease-relevant molecular targets.  We design and improve cutting-edge technologies for biomarker discovery and biopharmaceutical development, including platforms for immune-based therapies such as RNA vaccines and cellular therapies. Our broad in-house range of state-of-the-art TECHNOLOGIES AND PLATFORMS, some of which have been customized to meet the needs of industry, are also available for a number of cooperative research partnership models.

All About Our Research